Imbalance between CD8+CD28+ and CD8+CD28– T-cell subsets and its clinical significance in patients with systemic lupus erythematosus
Lupus Aug 14, 2019
Minning S, Xiaofan Y, Bingjie G, et al. - Cell isolation and flow cytometry analysis were used to examine the T-cell subsets by the researchers in order to assess the alterations in CD8+CD28–/CD8+CD28+ T-cell subset balance and in the CD8+CD28– Treg cell number and function in individuals with systemic lupus erythematosus (SLE). It was observed that in high-activity SLE individuals, the CD8+CD28+ T-cell subset was decreased, which was inversely related to the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and that the CD8+CD28-/CD8+CD28+ ratio was raised, which was positively associated with SLEDAI and with renal damage and inversely related to serum complement level, whereas the CD8+CD28- T-cell subset was progressed only in inactive individuals. Apoptosis of CD8+ T cells multiplied, and Fas, Fas ligand (FasL) and interleukin (IL)-6 expression were high, whereas cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) expression was low by the CD8+CD28+ T cell subset in the active SLE individuals and apoptosis was positively associated with SLEDAI and with the expression of Fas and FasL by the CD8+CD28+ T-cell subset in active SLE individuals. In active SLE individuals, IL-6 and CTLA-4 expression were noted to be low by the CD8+CD28- T cell subset. In conclusion, in active SLE individuals, high expression of Fas, FasL and IL-6 and low expression of CTLA-4 by the CD8+CD28+ T-cell subset promoted the activation-induced cell death of the CD8+CD28+ T-cell subset, leading to an imbalance of CD8+CD28-/CD8+CD28+ T cells, which exhibited a significant chahracteristic in the immunological pathogenesis of SLE. The CD8+CD28- T-cell subset could play some part in inactive SLE.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries